Zai Lab Limited ADR (NASDAQ:ZLAB) has a beta value of 43.96% and has seen 1.21 shares traded in the last trading session. The company, currently valued at $3.79B, closed the last trade at $36.93 per share which meant it lost -$15.25 on the day or 34.55% during that session. The ZLAB stock price is -20.06% off its 52-week high price of $44.34 and 56.65% above the 52-week low of $16.01.
The consensus among analysts is that Zai Lab Limited ADR (ZLAB) is Buy stock at the moment, with a recommendation rating of 47.42. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.42.
Zai Lab Limited ADR (NASDAQ:ZLAB) trade information
Sporting 34.55% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ZLAB stock price touched $36.93 or saw a rise of 12.07%. Year-to-date, Zai Lab Limited ADR shares have moved 82.03%, while the 5-day performance has seen it change -19.71%. Over the past 30 days, the shares of Zai Lab Limited ADR (NASDAQ:ZLAB) have changed 5.88%.
Wall Street analysts have a consensus price target for the stock at $55, which means that the shares’ value could jump 32.85% from current levels. The projected low price target is $55.0 while the price target rests at a high of $55.0. In that case, then, we find that the current price level is -48.93% off the targeted high while a plunge would see the stock gain -48.93% from current levels.
Zai Lab Limited ADR (ZLAB) estimates and forecasts
The company’s shares have gained 31.97% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 42.29%.
7 analysts offering their estimates for the company have set an average revenue estimate of 126.91M for the current quarter. 7 have an estimated revenue figure of 153.18M for the next ending quarter. Year-ago sales stood 100.5M and 102.27M respectively for this quarter and the next, and analysts expect sales will grow by 26.27% for the current quarter and 42.29% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 30.00% -3.18% over the past 5 years.
ZLAB Dividends
Zai Lab Limited ADR is expected to release its next earnings report on 2025-May-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Zai Lab Limited ADR (NASDAQ:ZLAB)’s Major holders
The top two institutional holders are WELLINGTON MANAGEMENT GROUP LLP with over 7.12 million shares worth more than $123.47 million. As of 2024-06-30, WELLINGTON MANAGEMENT GROUP LLP held 0.73% of shares outstanding.
The other major institutional holder is JANUS HENDERSON GROUP PLC, with the holding of over 6.53 million shares as of 2024-06-30. The firm’s total holdings are worth over $113.13 million and represent 0.6689% of shares outstanding.
